Skip to content
Film Television Auditions – Lifestyle
Author:
HOTH THERAPEUTICS, INC.
Hoth Therapeutics Announces Issuance of Chinese Patent for Cancer Cell-Targeting Technology
March 31, 2026
Hoth Therapeutics Deploys OpenClaw™ AI Platform to Accelerate Drug Discovery
March 26, 2026
Hoth Therapeutics Reports Positive HT-001 PK, Safety, and Clinical Activity Data in Cancer Patients with EGFR Therapy-Associated Skin Toxicities Showing ~77% Increase in Drug Exposure and Minimal Systemic Absorption
March 24, 2026
Hoth Therapeutics Reports Positive Female Preclinical Data Showing HT-VA Restores Cholesterol Levels and Improves Lipid Metabolism in MASLD Model
March 10, 2026
←
Previous Page
1
2